Market Closed -
Other stock markets
|
After market 01:29:37 am | |||
0.3525 EUR | -2.35% | 0.354 | +0.43% |
03/06 | Gensight Biologics S.A. Appoints William Monteith to Its Board of Directors | CI |
03/06 | Gensight Biologics S.A. Appoints Ivan Tortet as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.37% | 39.9M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- Gensight Biologics Pulls Marketing Authorization Application in Europe for Lumevoq Gene Therapy